Sentence examples similar to cost-effective standard of from inspiring English sources

We have compared a laborious and expensive 'gold standard' method for estimating Y-chromosomal lineage times – resequencing ∼9 Mb of DNA – with the much easier and more cost-effective standard approach of genotyping sets of Y-SNPs plus Y-STRs.

NDM is designed to facilitate the clinical research study designs needed to establish cost-effective integrated standard-of-care clinical options.

The 24-week single treatment with sofosbuvir + ribavirin is not cost-effective compared to standard care of treatment with an ICER of $88,833/QALY.

The cost effectiveness analysis suggests that ivabradine plus standard care has a high probability of being cost-effective versus standard care alone in patients with HF who are in sinus rhythm with left ventricular systolic dysfunction and have a baseline heart rate either ≥75 bpm or ≥70 bpm.

27 For example, some studies in this review indicated that DRV/r-based HAART was more cost-effective than other standard-of-care PI-based regimens among people living with HIV.

A recent report by the Canadian Agency for Drugs and Technologies in Health did conclude that HBOT for diabetic foot ulcers is cost-effective compared with standard methods of care but pointed out that even if seven-person HBOT chambers were used, Canada would need up to an additional 35 of these expensive machines (not to mention the staff to run them) (6).

The model showed that indacaterol produced cost savings and incremental health benefits over a range of time frames and is therefore a cost-effective alternative to current standard of care for the maintenance treatment of moderate and severe patients with COPD.

Results of probabilistic analysis are also presented in the form of cost-effectiveness acceptability curves (CEACs), which demonstrate the probability of supported employment being cost-effective relative to standard care at different levels of willingness to pay per extra unit of benefit, that is, at different cost-effectiveness thresholds (Fenwick et al., 2001).

Probabilistic sensitivity analysis indicates that, using a cost effectiveness threshold of £20 000 per QALY, ivabradine plus standard care has a greater than 0.95 probability of being cost-effective versus standard care alone in a population with a heart rate ≥75 bpm (figure 2), and over 0.70 probability in a population ≥70 bpm.

In summary, from a UK NHS perspective, ivabradine in combination with optimised standard care therapy, including β-blockade, has a high probability of being cost-effective versus standard care alone in patients with HF, who are in sinus rhythm with left ventricular systolic dysfunction and a baseline heart rate either ≥75 bpm or ≥70 bpm.

There was a 91% probability that nurse-led follow-up was cost-effective compared to standard follow-up, discarding quality-of-life effects (willingness to pay €0, Figure 3).